The East Asian gut microbiome is distinct from colocalized white subjects and connected to metabolic health

  1. Qi Yan Ang
  2. Diana L Alba
  3. Vaibhav Upadhyay
  4. Jordan E Bisanz
  5. Jingwei Cai
  6. Ho Lim Lee
  7. Eliseo Barajas
  8. Grace Wei
  9. Cecilia Noecker
  10. Andrew D Patterson
  11. Suneil K Koliwad  Is a corresponding author
  12. Peter J Turnbaugh  Is a corresponding author
  1. University of California, San Francisco, United States
  2. Pennsylvania State University, United States

Abstract

East Asians experience worse metabolic health outcomes compared to other ethnic groups at lower body mass indices; however, the potential role of the gut microbiota in contributing to these health disparities remains unknown. We conducted a multi-omic study of 46 lean and obese East Asian and White participants living in the San Francisco Bay Area, revealing marked differences between ethnic groups in bacterial richness and community structure. White individuals were enriched for the mucin-degrading Akkermansia muciniphila. East Asian subjects had increased levels of multiple bacterial phyla, fermentative pathways detected by metagenomics, and the short-chain fatty acid end-products acetate, propionate, and isobutyrate. Differences in the gut microbiota between the East Asian and White subjects could not be explained by dietary intake, were more pronounced in lean individuals, and were associated with current geographical location. Microbiome transplantations into germ-free mice demonstrated stable diet- and host genotype-independent differences between the gut microbiotas of East Asian and White individuals that differentially impact host body composition. Taken together, our findings add to the growing body of literature describing variation between ethnicities and provide a starting point for defining the mechanisms through which the microbiome may shape disparate health outcomes in East Asians.

Data availability

All 16S-seq and metagenomic sequencing data generated in the preparation of this manuscript have been deposited in NCBI's Sequence Read Archive under accession number PRJNA665061. Metabolomics results and metadata are available within this manuscript (Tables S2, S4, S5, and S9). Code for our manuscript will be uploaded to GitHub (https://github.com/turnbaughlab/2021_IDEO).

The following data sets were generated

Article and author information

Author details

  1. Qi Yan Ang

    University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  2. Diana L Alba

    University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  3. Vaibhav Upadhyay

    University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  4. Jordan E Bisanz

    University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8649-1706
  5. Jingwei Cai

    Pennsylvania State University, College Park, United States
    Competing interests
    No competing interests declared.
  6. Ho Lim Lee

    University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  7. Eliseo Barajas

    University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  8. Grace Wei

    University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  9. Cecilia Noecker

    University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  10. Andrew D Patterson

    Pennsylvania State University, College Park, United States
    Competing interests
    No competing interests declared.
  11. Suneil K Koliwad

    University of California, San Francisco, San Francisco, United States
    For correspondence
    Suneil.Koliwad@ucsf.edu
    Competing interests
    No competing interests declared.
  12. Peter J Turnbaugh

    University of California, San Francisco, San Francisco, United States
    For correspondence
    Peter.Turnbaugh@ucsf.edu
    Competing interests
    Peter J Turnbaugh, is on the scientific advisory board for Kaleido, Pendulum, Seres, and SNIPRbiome; there is no direct overlap between the current study and these consulting duties.Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0888-2875

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK114034)

  • Peter J Turnbaugh

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK11230401)

  • Suneil K Koliwad

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Protocols for all experiments involving mice were approved by the University of California, San Francisco Institutional Animal Care and Use Committee, and performed accordingly (UCSF IACUC numbers AN183950 and AN184143).

Human subjects: Informed consent was provided for all subjects participating in the study, which was approved by the UCSF Institutional Review Board.

Copyright

© 2021, Ang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,117
    views
  • 442
    downloads
  • 29
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Qi Yan Ang
  2. Diana L Alba
  3. Vaibhav Upadhyay
  4. Jordan E Bisanz
  5. Jingwei Cai
  6. Ho Lim Lee
  7. Eliseo Barajas
  8. Grace Wei
  9. Cecilia Noecker
  10. Andrew D Patterson
  11. Suneil K Koliwad
  12. Peter J Turnbaugh
(2021)
The East Asian gut microbiome is distinct from colocalized white subjects and connected to metabolic health
eLife 10:e70349.
https://doi.org/10.7554/eLife.70349

Share this article

https://doi.org/10.7554/eLife.70349

Further reading

    1. Microbiology and Infectious Disease
    Srinivasan Vijay, Nguyen Le Hoai Bao ... Nguyen Thuy Thuong
    Research Article

    Antibiotic tolerance in Mycobacterium tuberculosis reduces bacterial killing, worsens treatment outcomes, and contributes to resistance. We studied rifampicin tolerance in isolates with or without isoniazid resistance (IR). Using a minimum duration of killing assay, we measured rifampicin survival in isoniazid-susceptible (IS, n=119) and resistant (IR, n=84) isolates, correlating tolerance with bacterial growth, rifampicin minimum inhibitory concentrations (MICs), and isoniazid-resistant mutations. Longitudinal IR isolates were analyzed for changes in rifampicin tolerance and genetic variant emergence. The median time for rifampicin to reduce the bacterial population by 90% (MDK90) increased from 1.23 days (IS) and 1.31 days (IR) to 2.55 days (IS) and 1.98 days (IR) over 15–60 days of incubation, indicating fast and slow-growing tolerant sub-populations. A 6 log10-fold survival fraction classified tolerance as low, medium, or high, showing that IR is linked to increased tolerance and faster growth (OR = 2.68 for low vs. medium, OR = 4.42 for low vs. high, p-trend = 0.0003). High tolerance in IR isolates was associated with rifampicin treatment in patients and genetic microvariants. These findings suggest that IR tuberculosis should be assessed for high rifampicin tolerance to optimize treatment and prevent the development of multi-drug-resistant tuberculosis.

    1. Evolutionary Biology
    2. Microbiology and Infectious Disease
    Zachary H Williams, Alvaro Dafonte Imedio ... Welkin E Johnson
    Research Article Updated

    HERV-K(HML-2), the youngest clade of human endogenous retroviruses (HERVs), includes many intact or nearly intact proviruses, but no replication competent HML-2 proviruses have been identified in humans. HML-2-related proviruses are present in other primates, including rhesus macaques, but the extent and timing of HML-2 activity in macaques remains unclear. We have identified 145 HML-2-like proviruses in rhesus macaques, including a clade of young, rhesus-specific insertions. Age estimates, intact open reading frames, and insertional polymorphism of these insertions are consistent with recent or ongoing infectious activity in macaques. 106 of the proviruses form a clade characterized by an ~750 bp sequence between env and the 3′ long terminal repeat (LTR), derived from an ancient recombination with a HERV-K(HML-8)-related virus. This clade is found in Old World monkeys (OWM), but not great apes, suggesting it originated after the ape/OWM split. We identified similar proviruses in white-cheeked gibbons; the gibbon insertions cluster within the OWM recombinant clade, suggesting interspecies transmission from OWM to gibbons. The LTRs of the youngest proviruses have deletions in U3, which disrupt the Rec Response Element (RcRE), required for nuclear export of unspliced viral RNA. We show that the HML-8-derived region functions as a Rec-independent constitutive transport element (CTE), indicating the ancestral Rec–RcRE export system was replaced by a CTE mechanism.